Smartphone-based quantitative biomarker analysis in clinical diagnostics, suggesting a robust, high-throughput solution.
-ELISA platform enables high-throughput biomarker quantification directly from microplates without specialized instrumentation, providing a cost-effective, robust, and portable solution for clinical diagnostics.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: